Ify Mordi

Cardiologist. Imaging. Heart failure. Senior Lecturer in Cardiology @UoDMedicine. @TheBHF Intermediate Fellow

[Heart_BMJ @Heart_BMJ]

Podcast : Heart failure diagnosis - why earlier is better.

In this episode of the Heart podcast, Digital Media Editor @jhfrudd is joined by Dr Ify Mordi from the University of Dundee. They discuss his publication concerning the outcomes of those diagnosed with heart failure in the community compared to those in the hospital.

Podcast: https://t.co/4G8NVfHEt9

Paper: https://t.co/QhU2pUISXo

[ISRCTN: the UK's Clinical Study Registry @ISRCTN]

A cohort study to evaluate the relationship between cardiac microvascular dysfunction, diabetes and cardiac structural and functional abnormalities

Read about the MIDAS-HEART study by @docifymordi registered at #ISRCTN

https://t.co/wTq7wgpp1z

[British Cardiovascular Society @BritishCardioSo]

🌟 Got time for a free webinar in September? 🌟

Date: Monday 22 September
Time: 6:30pm - 8pm (BST)

This 90-minute online session will focus on Cardio-Renal-Metabolic care.

Led by Professor @sbw_cardio and featuring talks from Professor Chim Lang, @docifymordi and Dr @AndrewFrankel1.

Book your free place > https://t.co/rlQ1IwtqRy

@ShouvikHaldar

#Cardiology #CardioEducation #CardioTwitter #CaReMe

[James Cantley Lab @JamesCantleyLab]

Thanks to @BT1DUK for organising a fantastic Research Update event in Dundee on Wednesday. James Cantley, Ify Mordi and Rory McCrimmon presented on their different approaches to diabetes research, followed by an insightful Q&A. Great to connect with the Scottish T1D community!

[Heart_BMJ @Heart_BMJ]

Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study https://t.co/BEzYJUtpkQ

[Circulation @CircAHA]

Testing SGLT2 inhibitors in patients with heart failure and type 1 diabetes: the need for a trial @docifymordi https://t.co/kqIaAmQycl

[Prof Kamlesh Khunti @kamleshkhunti]

AI models could accurately predict MACE outcomes from routine retinal screening photographs

Comparable performance to traditional clinical risk assessment in a diabetic cohort.

https://t.co/iVevjGR3g8

[RedStar @RedStarAI]

Thrilled to see our article featured in Futurescot!

This is just the beginning of what’s possible when innovative technology meets a patient-centered approach to healthcare.

Read the article below 👇🏻

[RedStar @RedStarAI]

Dr Ify Mordi spoke with STV News (video credit) about our research on using #AI to improve the identification and management of #heartfailure patients. By optimizing #carepathways through #technology, we have the potential to greatly enhance the quality of life for many people.

[Ify Mordi @docifymordi]

@sybanerjee Well done!

[Breakthrough T1D UK @BT1DUK]

We're excited to announce a new @JDRF-funded clinical trial of a life-saving treatment for people with #Type1Diabetes and #HeartFailure, led by @docifymordi at @UoDMedicine 🔬💊

Find out more: https://t.co/onZSgJP7Qm

#GBDoc #Research

[Justin Chiong @justinchiong_]

Better late than never! In Barcelona for Day 3 of #EACVI2023 to present our work on HFpEF, echo structural abnormalities and prognostic implications. @UoDMedicine @NHSTayside @docifymordi #CardioTwitter

[Ify Mordi @docifymordi]

@GrahamRena1 Congratulations!

[RR BaligaMD, Professor & Cardiologist @RRBaligaMD]

Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors https://t.co/xcR843sz3J @docifymordi @UoDMedicine @UoDLifeSciences @ClinicalKey #MedEd #CardioEd #CardioOnc #Diabetes #heartdisease #heartfailure @hfsa #Medtwitter #Cardiotwitter @DLBHATTMD @TheBHF

[Ify Mordi @docifymordi]

@NonyGMordi @gillianvance4 @DocThomson @BBMeded @lorettam3 @NatalieMordi Well, well deserved, fantastic!

[Ify Mordi @docifymordi]

@cardiojaydoc02 @DavidLBrownMD To be fair, he seems pretty happy about it, so perhaps he does “feel better”!

[Open Research, University of Dundee @UoDOpenResearch]

🔓 #OA
Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction
➡️https://t.co/8fxruwHjZt
@UoDMedicine @UoDCellSigImm @UoDLifeSciences @CalumForteath @JillBelch Prof Chim Lang @docifymordi @SimonAr09230172 Prof Faisel Khan
#Endothelium #VascularBiology

[Open Research, University of Dundee @UoDOpenResearch]

🔓 #OpenAccess
Type 2 Diabetes, Metabolic traits and Risk of Heart Failure: a Mendelian Randomization study
➡️https://t.co/Q162izHkqV
@UoDMedicine @docifymordi @ColinPa11632406 @ezpearson Prof Chim Lang
#MendelianRandomization #T2D #HeartFailure

[European Society of Cardiology Journals @ESC_Journals]

Should age be considered when treating #HeartFailure patients with #betablocker therapy? Data from BIOSTAT in #EJHF suggest no dose response relationship with higher age for #betablocker therapy. Is there an optimal dose-age relationship for betablockers? https://t.co/OANNpZrESv

[Graham Rena @GrahamRena1]

First up we have a review on diabetes drugs and CV protection- a very topical area just now, really enjoyed writing this with Chim Lang and @docifymordi and the writing definitely made lockdown more bearable 😁 https://t.co/o1C8cJ83rA 2/